The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence

被引:0
|
作者
Avramenko, N. V. [1 ,2 ]
Kabachenko, O. V. [2 ]
Barkovskyi, D. Ye. [2 ]
Sierykh, K. V. [2 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Zaporizhia, Ukraine
[2] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Dept Obstet Gynecol & Reprod Med, Zaporizhia, Ukraine
关键词
obesity; metabolic syndrome; polycystic ovary syndrome; adolescence; diagnosis; treatment; prevention; ASSOCIATIONS; MANAGEMENT; OBESITY; HEALTH; RISK;
D O I
10.14739/2310-1210.2023.3.251479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary -de-pendent pathology. One of the major consequences of weight problems is metabolic syndrome (MS). There are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension). Obesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome ty-pical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia). First-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 50 条
  • [41] Polycystic Ovary syndrome Metabolic Syndrome Predisposition in Puberty
    Geronikolou, Styliani
    Bacopoulou, Flora
    Chryssanthopoulos, Stavros
    Cokkinos, Dennis
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 485 - 485
  • [42] The effect of exenatide on metabolic syndrome with polycystic ovary syndrome
    Chen, Lin
    Long, Tao
    Zheng, Siyuan
    Liu, Xin
    Yan, Jiahe
    Mai, Tingting
    Gong, Yi
    Liu, En
    Xie, Yijuan
    Chen, Hui
    Lin, Rong
    Zheng, Yongxiong
    Luo, Hengcong
    Zhang, Ying
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [43] Prevalence of metabolic syndrome in women with polycystic ovary syndrome
    Panidis, Dimitrios
    Macut, Djuro
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    Mikhailidis, Konstantinos
    Kandaraki, Eleni A.
    Tsourdi, Elena A.
    Tantanasis, Theoharis
    Mavromatidis, George
    Katsikis, Ilias
    CLINICAL ENDOCRINOLOGY, 2013, 78 (04) : 586 - 592
  • [44] Obesity, Adipokines and Metabolic Syndrome in Polycystic Ovary Syndrome
    Carmina, Enrico
    POLYCYSTIC OVARY SYNDROME: NOVEL INSIGHT INTO CAUSES AND THERAPY, 2013, 40 : 40 - 50
  • [45] Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?
    Shah, D.
    Rasool, S.
    CLIMACTERIC, 2016, 19 (01) : 7 - 16
  • [46] Stress in women - Metabolic syndrome and polycystic ovary syndrome
    Diamanti-Kandarakis, Evanthia
    Economou, Frangiskos
    STRESS, OBESITY, AND METABOLIC SYNDROME, 2006, 1083 : 54 - 62
  • [47] Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping
    Caserta, Donatella
    Adducchio, Gloria
    Picchia, Simona
    Ralli, Eleonora
    Matteucci, Eleonora
    Moscarini, Massimo
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (06) : 397 - 402
  • [48] Polycystic ovary syndrome, adipose tissue and metabolic syndrome
    Delitala, Alessandro P.
    Capobianco, Giampiero
    Delitala, Giuseppe
    Cherchi, Pier Luigi
    Dessole, Salvatore
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 296 (03) : 405 - 419
  • [49] Association Between Polycystic Ovary Syndrome and Metabolic Syndrome
    Martin Velez, Leandro
    Beatriz Motta, Alicia
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (35) : 3999 - 4012
  • [50] METABOLIC SYNDROME IN POLYCYSTIC OVARY SYNDROME TUNISIAN WOMEN
    Smaoui, Fatma
    Chaabouni, Khansa
    Elleuch, Aida
    Boudaya, Mariem
    Mezghani, Chema
    Chaabene, Kais
    Frikha, Madiha
    Ayadi, Fatma
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E271 - E271